Answers are grounded in this paper and cite their sources.
This report helps biosafety professionals understand the evolving regulatory framework for gene therapy products. Knowledge of the guidance documents discussed in this report will assist biosafety professionals in addressing issues pertaining to shedding and environmental impact during IBC review of clinical trials.
No takes yet. Share an insight, caveat, or question.
Eisenman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: